A cancer risk surrounding a technologically advanced and minimally invasive surgery for removing the uterus has prompted the Food and Drug Administration to issue a warning discouraging the medical procedure.
In 2009, the U.S. Food and Drug Administration (FDA) announced that it intended to release a guidance document explaining how it will regulate industry’s use of social media to advertise products or communicate with...more
In This Issue:
- Forecast for the Physician Payments Sunshine Act: Partly Cloudy
- Document Preservation Notices and the Lists of Who Receive Them: Are They Discoverable?
- FDA Warning Letters Through...more
Back to Top